4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-023521
President & COO sold 100,000 shares at $11.45 ($1,145,000)
- President & COO acquired 100,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Venker Eric · President & COO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-20 | Exercise or conversion : show line 1 in the form 10b5-1 | +100,000 | $3.85 | $385,000 | 1,562,223 | D |
| 2025-06-20 | Sale : show line 2 in the form 10b5-1 | −100,000 | $11.45 | $1,145,000 | 1,462,223 | D |
| Open-market sales · 100,000 sh · avg $11.45 · $1,145,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-20 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −100,000 | 8,238,897 | D |
Loading xslF345X05/form4.xml…